Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

EBUS-TBNA in the rapid microbiological diagnosis of drug-resistant mediastinal tuberculous lymphadenopathy.

Chhajed PN, Vaidya PJ, Mandovra NP, Chavhan VB, Lele TT, Nair R, Leuppi JD, Saha A.

ERJ Open Res. 2019 Nov 15;5(4). pii: 00008-2019. doi: 10.1183/23120541.00008-2019. eCollection 2019 Oct.

2.

Factors affecting outcomes of individualised treatment for drug resistant tuberculosis in an endemic region.

Saha A, Vaidya PJ, Chavhan VB, Pandey KV, Kate AH, Leuppi JD, Tamm M, Chhajed PN.

Indian J Tuberc. 2019 Apr;66(2):240-246. doi: 10.1016/j.ijtb.2017.04.001. Epub 2017 Apr 28.

PMID:
31151491
3.

Inconsistency in the reporting of antitubercular drug susceptibility tests in an endemic region.

Saha A, Vaidya PJ, Chavhan VB, Pandey KV, Kate AH, Chhajed PN.

Lung India. 2017 Sep-Oct;34(5):427-429. doi: 10.4103/0970-2113.213840.

4.

Diagnostic value of core biopsy histology and cytology sampling of mediastinal lymph nodes using 21-gauge EBUS-TBNA needle.

Vaidya PJ, Saha A, Kate AH, Pandey K, Chavhan VB, Leuppi JD, Chhajed PN.

J Cancer Res Ther. 2016 Jul-Sep;12(3):1172-1177. doi: 10.4103/0973-1482.197535.

5.

Bronchoscopic and surgical management of rare endobronchial tumors.

Pandey K, Vaidya PJ, Kate AH, Chavhan VB, Jaybhaye P, Patole K, Deshpande RK, Chhajed PN.

J Cancer Res Ther. 2016 Apr-Jun;12(2):1093-7. doi: 10.4103/0973-1482.186692.

Supplemental Content

Loading ...
Support Center